Universe Pharmaceuticals holds annual shareholder meeting

• Universe Pharmaceuticals held its annual shareholder meeting on Sept. 30, 2026, with all items passed.
• Director reappointments were endorsed for Gang Lai, Lin Yang, Jiawen Pang, Ding Zheng, Yongping Yu.
• Share consolidation plan was authorized, conditional on a defined Nasdaq bid-price trigger; no consolidation was confirmed as executed.
• Amended and restated memorandum of association was adopted, contingent on the share consolidation taking effect; implementation was not confirmed.
• Authority to adjourn the meeting, if needed to secure sufficient votes, was granted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universe Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-107197), on October 06, 2026, and is solely responsible for the information contained therein.